These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 328950

  • 1. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
    Yu VL, Rhame FS, Pesanti EL, Axline SG.
    JAMA; 1977 Aug 29; 238(9):943-7. PubMed ID: 328950
    [Abstract] [Full Text] [Related]

  • 2. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM, McGee ZA, Alford RH.
    Arch Intern Med; 1978 Feb 29; 138(2):201-5. PubMed ID: 415674
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ, Simberkoff MS, Rahal JJ.
    J Antimicrob Chemother; 1985 Aug 29; 16(2):227-34. PubMed ID: 3934125
    [Abstract] [Full Text] [Related]

  • 4. Amikacin therapy for serious gram-negative infection.
    Pollock AA, Berger SA, Richmond AS, Simberkoff MS, Rahal JJ.
    JAMA; 1977 Feb 07; 237(6):562-4. PubMed ID: 576282
    [Abstract] [Full Text] [Related]

  • 5. Gentamicin-resistant Serratia marcescens endophthalmitis.
    Gammon JA, Schwab I, Joseph P.
    Arch Ophthalmol; 1980 Jul 07; 98(7):1221-3. PubMed ID: 6994702
    [Abstract] [Full Text] [Related]

  • 6. Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
    Tally FP, Louie TJ, O'Keefe P, Gorbach SL, Bartlett JG.
    J Infect Dis; 1976 Nov 07; 134 SUPPL():S428-32. PubMed ID: 993634
    [Abstract] [Full Text] [Related]

  • 7. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL, Alvarez S, Ortega G, Verghese A, Holtsclaw-Berk SA.
    Arch Intern Med; 1986 Mar 07; 146(3):538-41. PubMed ID: 3954526
    [Abstract] [Full Text] [Related]

  • 8. Controlled comparison of amikacin and gentamicin.
    Smith CR, Baughman KL, Edwards CQ, Rogers JF, Lietman PS.
    N Engl J Med; 1977 Feb 17; 296(7):349-53. PubMed ID: 319355
    [Abstract] [Full Text] [Related]

  • 9. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE, McGee ZA, Farrar WE.
    J Infect Dis; 1980 Mar 17; 141(3):346-50. PubMed ID: 6988523
    [Abstract] [Full Text] [Related]

  • 10. Amikacin therapy of gram-negative bacteremia.
    Tally FP, Gorbach SL.
    Am J Med; 1977 Jun 17; 62(6):936-9. PubMed ID: 868909
    [Abstract] [Full Text] [Related]

  • 11. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
    Craven PC, Jorgensen JH, Kaspar RL, Drutz DJ.
    Am J Med; 1977 Jun 17; 62(6):902-10. PubMed ID: 326046
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of amikacin sulfate (Amikin). A new aminoglycoside antibiotic.
    Schiffman DO.
    JAMA; 1977 Oct 03; 238(14):1547-50. PubMed ID: 578232
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Review of 152 patients with bacteremias treated with amikacin.
    Tally FP, Gorbach SL.
    Am J Med; 1977 Jun 03; 62(6):940-4. PubMed ID: 868910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.